Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lammert

Showing results (971-980 of 1,090) with videos related to

Pageof 109
Sort By:
Biorxiv : the Preprint Server for Biology|January 7, 2025
Pro-cognitive reshaping of neuronal dynamics by a human CSF-based factorMarc Dos Santos, Marc P Forrest, Ewa Bomba-Warczak, et al.
Molecular Metabolism|July 14, 2023
Protection of pancreatic islets from oxidative cell death by a peripherally-active morphinan with increased drug safetyOkka Scholz, Elena Huß, Silke Otter, et al.
Journal of Gastroenterology and Hepatology|December 10, 2015
Improvement of platelets after SVR among patients with chronic HCV infection and advanced hepatic fibrosisAdriaan J van der Meer, Raoel Maan, Bart J Veldt, et al.
Gastroenterology|April 7, 2009
Antifibrotic effects of CXCL9 and its receptor CXCR3 in livers of mice and humansHermann E Wasmuth, Frank Lammert, Mirko Moreno Zaldivar, et al.
Journal of Diabetes Research|May 30, 2017
The <i>CNDP1</i> (CTG)<sub>5</sub> Polymorphism Is Associated with Biopsy-Proven Diabetic Nephropathy, Time on Hemodialysis, and Diabetes DurationThomas Albrecht, Shiqi Zhang, Jana D Braun, et al.
International Journal of Molecular Sciences|December 20, 2017
Vitamin D and Its Analogues Decrease Amyloid-β (Aβ) Formation and Increase Aβ-DegradationMarcus O W Grimm, Andrea Thiel, Anna A Lauer, et al.
European Journal of Cancer (Oxford, England : 1990)|September 5, 2020
CONKO-006: A randomised double-blinded phase IIb-study of additive therapy with gemcitabine + sorafenib/placebo in patients with R1 resection of pancreatic cancer - Final resultsM Sinn, T Liersch, H Riess, et al.
Radiology|November 18, 2025
A Prospective Controlled Trial of Large Language Model-based Simplification of Oncologic CT Reports for Patients with CancerPhilipp Prucker, Keno K Bressem, Jan Peeken, et al.
Cell Reports|June 9, 2023
Pancreatic islet protection at the expense of secretory function involves serine-linked mitochondrial one-carbon metabolismAngela Pelligra, Jessica Mrugala, Kerstin Griess, et al.
Frontiers in Immunology|March 10, 2022
Unspecific CTL Killing Is Enhanced by High Glucose <i>via</i> TNF-Related Apoptosis-Inducing LigandWenjuan Yang, Andreas Denger, Caroline Diener, et al.
Pageof 109

Showing results (971-980 of 1,090) with videos related to

Sort By:
Pageof 109
Biorxiv : the Preprint Server for Biology|January 7, 2025
Pro-cognitive reshaping of neuronal dynamics by a human CSF-based factorMarc Dos Santos, Marc P Forrest, Ewa Bomba-Warczak, et al.
Molecular Metabolism|July 14, 2023
Protection of pancreatic islets from oxidative cell death by a peripherally-active morphinan with increased drug safetyOkka Scholz, Elena Huß, Silke Otter, et al.
Journal of Gastroenterology and Hepatology|December 10, 2015
Improvement of platelets after SVR among patients with chronic HCV infection and advanced hepatic fibrosisAdriaan J van der Meer, Raoel Maan, Bart J Veldt, et al.
Gastroenterology|April 7, 2009
Antifibrotic effects of CXCL9 and its receptor CXCR3 in livers of mice and humansHermann E Wasmuth, Frank Lammert, Mirko Moreno Zaldivar, et al.
Journal of Diabetes Research|May 30, 2017
The <i>CNDP1</i> (CTG)<sub>5</sub> Polymorphism Is Associated with Biopsy-Proven Diabetic Nephropathy, Time on Hemodialysis, and Diabetes DurationThomas Albrecht, Shiqi Zhang, Jana D Braun, et al.
International Journal of Molecular Sciences|December 20, 2017
Vitamin D and Its Analogues Decrease Amyloid-β (Aβ) Formation and Increase Aβ-DegradationMarcus O W Grimm, Andrea Thiel, Anna A Lauer, et al.
European Journal of Cancer (Oxford, England : 1990)|September 5, 2020
CONKO-006: A randomised double-blinded phase IIb-study of additive therapy with gemcitabine + sorafenib/placebo in patients with R1 resection of pancreatic cancer - Final resultsM Sinn, T Liersch, H Riess, et al.
Radiology|November 18, 2025
A Prospective Controlled Trial of Large Language Model-based Simplification of Oncologic CT Reports for Patients with CancerPhilipp Prucker, Keno K Bressem, Jan Peeken, et al.
Cell Reports|June 9, 2023
Pancreatic islet protection at the expense of secretory function involves serine-linked mitochondrial one-carbon metabolismAngela Pelligra, Jessica Mrugala, Kerstin Griess, et al.
Frontiers in Immunology|March 10, 2022
Unspecific CTL Killing Is Enhanced by High Glucose <i>via</i> TNF-Related Apoptosis-Inducing LigandWenjuan Yang, Andreas Denger, Caroline Diener, et al.
Pageof 109